More Than Skin Deep – the Effects of Ultraviolet Radiation on Cathepsin K and Progerin Expression in Cultured Dermal Fibroblasts

Abstract

Introduction

Photoaging is a premature skin aging developing secondarily to the excessive exposure to ultraviolet radiation. Due to its complexity, an exact mechanism of photoaging has not been found yet; however, recent research has shown two new emerging players in this process – cathepsin K and progerin.

Aim

To evaluate how different wavelengths of ultraviolet radiation (UVA, narrowband UVB and broadband UVB) influence cathepsin K and progerin protein and mRNA expression in dermal cultured fibroblasts.

Materials and Methods

Primary human dermal fibroblasts (Detroit 551, ATCC CCL-110) were cultured and irradiated with UVA, narrowband UVB (UVBnb) and broadband UVB (UVBwb). Fibroblasts were irradiated with 2 protocols: single high-dose exposure to UVR with protein/mRNA extraction immediately after exposure, 24 h after exposure and 48 h after exposure, and repeated (0 h, 24 h and 48 h) low-dose exposure to UVR with protein/mRNA extraction 48 h after first exposure.

Results

Single high doses of UVA, UVBwb and UVBnb resulted in decreased expression of cathepsin K and progerin protein/mRNA in all subsequent time points. Repeated exposure to low doses of UVA results in significant increase of progerin mRNA and significant decrease of progerin protein after 48 h, but repeated exposure to UVBwb and UVBnb resulted in decreased progerin mRNA and protein expression. Repeated exposure to UVA, UVBwb and UVBnb resulted in decreased cathepsin K protein and mRNA expression.

Conclusion

The results suggest that there could be another progerin/cathepsin K regulatory pathway, which has not been described yet. Being contradictory with previous research, the influence of ultraviolet radiation on progerin and cathepsin K needs to be further elucidated.

Keywords:

• progerin
• cathepsin K
• photoaging

Introduction

Photoaging is a continuous and progressive process occurring in response to chronic exposure to ambient sunlight, which is a mixture of ultraviolet radiation types A and B (UVA, UVB), however their properties differ. UVA affects the deeper layers of the skin responsible for the degradation of the extracellular matrix and increased formation of reactive oxygen species within the dermis;^1,2 UVB, on the other hand, can stimulate inflammation and formation of DNA photolesions.^3,4 The combination of these wavelengths results in complex interplay between angiogenic, immunosuppressive and elastolytic activity, and their exact effects are still under investigation. It also remains unsolved how different types of ultraviolet radiation (UVR) participate in photoaging. Thus, photoaging should be considered premature skin aging secondary to excessive exposure to UVR.⁵ One of the hallmarks of photoaging is the aggregation of dystrophic elastin which can occur via its extracellular degradation orchestrated by matrix metalloproteinases,^6,7 as well as intracellular degradation predominantly controlled by cathepsin K (CatK),⁸ which degrades elastin in the lysosomes of dermal fibroblasts.⁷ Cathepsin K belongs to the cysteine protease family, and is involved in the degradation of collagen I, elastin and gelatine.^9,10 Cathepsin K, predominantly expressed in human osteoclasts, is responsible for bone remodelling, however the latest research shows that cathepsin K could be involved in the pathogenesis of skin tumors e.g. malignant melanoma and basal cell carcinoma,^11,12 as well as skin aging¹³ and the development of psoriasis-like lesions.¹⁴ While matrix metalloproteases have been extensively studied in terms of photoaging, there is still little known about cathepsin K in this context.

In addition to the extracellular matrix disequilibrium present in photoaged skin it seems that a new key player has emerged – a progerin. For several years progeroid syndromes, especially Hutchinson–Gilford progeria syndrome (HGPS),¹⁵ served as model diseases in research concerning all types of premature aging. HGPS is caused by a de novo point G608G (GGC→GGT) mutation in the LMNA gene encoding prelamin A.¹⁶ Normally, prelamin A undergoes a series of post-translational modifications which include attaching a farnesyl group onto C-terminal cysteine and cleavages catalyzed by a zinc-metalloprotease ZMPSTE24. ZMPSTE24 cleaves 15 C-terminal residues in prelamin A (aa 647–661) and removes farnesyl from prelamin A, giving rise to fully functional lamin A, which along with lamin B and C maintains the structural stability of the cell nucleus.¹⁷ Farnesylation is a key step in this process, allowing prelamin A to attach temporarily to the nuclear membrane.¹⁶ In HGPS, the point mutation in the LMNA gene results in a cryptic splicing site within exon 11 which disrupts the removal of 150 3ʹ-terminal nucleotides from this exon, resulting in synthesis of Δ150 LMNA mRNA. After translation of Δ150 LMNA mRNA, an isoform of lamin A with 50 amino acids (Δ50 lamin A) deleted emerges, and is commonly referred to as progerin.¹⁷ Since the ZMPSTE24 cleavage site is lost, progerin remains constantly farnesylated thus resulting in its accumulation within the nuclear envelope and an inability to stabilize the cell nucleus.¹⁸ The nucleus, devoid of lamin A, is abnormally shaped and has a reduced ability to divide, due to the disruption of chromatin remodeling, impaired DNA repair mechanisms and telomere shortening.^15,19–21 It has also been shown that the abnormal accumulation of progerin occurs, not only in HGPS, but also in normally senescing cells,^16,22 indicating that increased progerin expression could be considered as a hallmark of cell aging, however the results are still inconclusive.²³ One of the most recent findings indicates that progerin could also be associated with UV-induced skin aging.¹⁵

Due to many non-specific and contradictory findings regarding the involvement of cathepsin K and progerin in photoaging and their promising role in skin anti-aging therapies,^7,24 we aimed to evaluate how different wavelengths of UVR influence their expression in cultured dermal fibroblasts.

Materials and Methods

Cell Cultures

Primary human dermal fibroblasts (Detroit 551, ATCC CCL-110) were cultured using manufacturer’s protocol. Eagle’s Minimum Essential Medium (EMEM) with addition of 5% Fetal Bovine Serum (FBS) and 1% of Penicillin-Streptomycin solution was used as medium. All reagents were purchased at ATCC.

UVA/UVB Irradiations

Irradiations were performed using TL20W/01 narrowband UVB lamps with spectral output 305–315 nm (Philips, Germany), TL20W/12 UVB lamps with spectra output 285–350 nm and TL10RS UVA lamps with spectral output 320–400 nm (Philips, Germany). The exact dose and irradiation time were calculated according to manufacturer's protocols. In the course of the experiment, cells were irradiated with UVA, UVB narrowband (UVBnb) and UVB broadband (UVBwb) according to the protocol:

Exposure to a High Dose of Radiation

- UVA 150 kJ/m², protein was isolated immediately after exposure, 24 h after exposure and 48 h after exposure;

- UVBnb 300 J/m², protein was isolated immediately after exposure, 24 h after exposure and 48 h after exposure;

- UVBwb 300 J/m², protein was isolated immediately after exposure, 24 hours after exposure and 48h after exposure;

Exposure to a Low, Repetitive Dose of Radiation

- UVA 50 kJ/m² repeated after 24 h and 48 h (total dose 150 kJ/m²), protein isolated after the third exposure;

- UVBnb 100 J/m² repeated after 24 h and 48 h (total dose 300 J/m²), protein isolated after the third exposure;

- UVBwb 100 J/m² repeated after 24 h and 48 h (total dose 300 J/m²), protein isolated after the third exposure.

Western Blots

Cells were lysed in EBC buffer (50 mM Tris pH 8.0; 120 mM NaCl; 0.5% NP-40) supplemented with protease and phosphatase inhibitors. Total protein (100 µg) was resolved on denaturing 10% polyacrylamide gels, transferred to nitrocellulose membranes or PVDF (Millipore), and blotted with the indicated primary antibodies: Anti-cathepsin K antibody and Anti-progerin antibody (Abcam, USA) followed by incubation with appropriate secondary antibody. Sites of antibody binding were visualized by enhanced chemiluminescence detection kit (Bio-Rad).

qPCR

Total RNA was extracted with the RNAqueous™ Total RNA Isolation Kit and reverse transcribed into cDNA using a RevertAid First Strand cDNA Synthesis Kit according to the manufacturer's protocol. Quantitative real-time PCR was performed using a CFX96 Touch Real-Time PCR (BioRad). The reaction (12 µL) contained 0.2 nmol of forward and reverse primer, cDNA template, water and SYBR^® Green PCR Master Mix. Reactions were incubated at 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 56°C for 1 min. The following gene-specific primers were used: F: 5′-GGAGCTGACTTCCGCAATCCCG-3′ and R: 5′-TGTCTGGCTTCGTTTCGGCAGC-3′ for cathepsin K; F: 5′-TCAGGAGCCCAGAGCCCCCAGAAC-3′ and R: 5′-GGGTTATTTTTCTTTGGCTTCA-3′ for progerin. Gene expression levels were normalized to the level of GADPH using the following primers: F: 5ʹ-ACAGTTGCCATGTAGACC-3ʹ and R: 5ʹ-TTGAGCACAGGGTACTTTA-3ʹ and quantitative gene expression was calculated with comparative ΔCt method.

Results

UVA

UVA decreased cathepsin K and progerin protein expression in cultured primary human fibroblasts. It was observed both after single (150 kJ/m²) and repeated (3x50 kJ/m²) irradiation which resembled acute and chronic exposure to UVA, respectively. It was found that a single high 150 kJ/m² dose of UVA irradiation resulted in decreased expression of cathepsin K protein in all subsequent time points (77%, 79% and 88% of loading control expression), however no significant difference between each time point has been noted (p = 0.2177). RT-qPCR showed decrease of cathepsin K mRNA in all subsequent time points (-ΔCt values: −5.4, −8.1 and −1.8, p = 0.0087). Further analysis did not reveal significant differences between T0 and T1/T2 points. Repeated low doses of UVA (3x50 kJ/m²) decreased cathepsin K protein expression to a much greater extent than the single high dose of UVA (150 kJ/m²) (70% vs 88% of loading control expression respectively, p = 0.0171), however the differences between cathepsin K mRNA levels were not significant (p = 0.8585).

The single high 150 kJ/m² dose of UVA irradiation resulted in decreased expression of progerin in subsequent time points (22%, 22% and 78% of loading control expression). The increase of progerin protein expression after 48 h compared with 0 h has been found to be significant (p = 0.0001). RT-qPCR revealed a decrease of progerin mRNA in all subsequent time points (-ΔCt values: −4.2, −3.4, −2.7 respectively). Repeated low doses of UVA (3x50 kJ/m²) decreased progerin protein expression to a much greater extent than a single high dose of UVA (150 kJ/m²) (43% vs 72% of loading control expression respectively, p = 0.0033). RT-qPCR revealed that repeated exposure to low doses of UVA results in a significant increase of progerin mRNA after 48 h compared with irradiation with a single high dose (0.3 vs −2.7, p = 0.0116 respectively).

Broadband UVB

Cathepsin K protein expression decreased to 27% in T0, to 19% in T1 and to 56% in T2 which has been partially reflected in mRNA levels (−4 in T0, 0.4 in T1 and −3.8 in T2). Repeated exposure to UVBwb decreased cathepsin K protein expression and mRNA levels (61%, -dCt=−2.1). Exposure to a single high dose of UVBwb resulted in decreased progerin protein expression (T0 = 27%, T1 = 19%, T2 = 56%) and progerin mRNA (T0 = −1.8, T1 = −3.5, T2 = −1.9). Repeated low dose of UVBwb decreased progerin protein expression to a much greater extent than a single high dose (22% vs 56%, p = 0.0004), however it has not been observed for progerin mRNA (−1.9 vs −1.6 respectively).

Narrowband UVB

Irradiation with a single high dose of UVBnb also resulted in a decrease of cathepsin K protein expression (T0 = 92%, T1 = 88%, T2 = 63%, the difference between T0 and T2 was significant, p<0.05) with decreased mRNA levels (T0 = −1.5, T1 = −3.0, T2 = −1.5). Repeated exposure to UVBnb significantly decreased cathepsin K protein and mRNA expression (47%, p = 0.0001; -dCt = −4.4, p = 0.0129 respectively) in comparison to single high UVBnb dose. A single high dose of UVBnb resulted in decreased progerin protein expression (T0 = 56%, T1 = 58%, T2 = 56%, the difference between T0 and T1/T2 was found to be significant) followed by decreased mRNA levels (T0 = −1.8, T1 = −3.5, T2 = −1.9). Repeated exposure to UVBnb resulted in a significant decrease of progerin protein (21%, p<0.0001) and an increase in mRNA levels (-dCt = −0.4, p = 0.0006) compared with single high UVBnb dose. Detailed results are shown in Tables 1–2 and –figure2.

Table 1 Expression of Cathepsin K and Progerin Protein/mRNA After Single High Dose Irradiation

	UVA				UVBbwb				UVBnb
	Cathepsin K		Progerin		Cathepsin K		Progerin		Cathepsin K		Progerin
	Protein	mRNA	Protein	mRNA	Protein	mRNA	Protein	mRNA	Protein	mRNA	Protein	mRNA
0 h	76.92±5.34	−5.4	22.12±2.69	−4.2	27.25±3.02	−4.0	56.25±8.41	−1.8	91.52±11.23	−2.6	66.45±2.16	−2.9
24 h	78.86±9.10	−8.1	22.67±0.82	−3.4	19.47±1.12	0.4	57.57±5.96	−3.5	87.92±6.07	−7.8	52.92±4.21	−5.3
48 h	87.91±6.68	−1.8	71.94±7.37	−2.7	55.77±1.00	−3.8	56.31±5.13	−1.9	63.41±0.26	−0.9	54.42±1.70	−2.4
p-value	0.2177	0.0087	0.0001	0.2435	0.0009	0.0625	0.9629	0.3135	0.0067	0.0659	0.0023	0.1372

Table 2 Expression of Cathepsin K and Progerin Protein/mRNA After Repeated Low Dose Irradiation vs High Dose Irradiation

Irradiation			Single High Dose	Repeated Low Dose	p-value
UVA	Cathepsin	Protein	87.91±6.68	69.91±4.29	0.0171
		mRNA	−1.8	−1.4	0.8585
	Progerin	Protein	71.94±7.37	42.51±4.35	0.0033
		mRNA	−2.7	0.3	0.0116
UVBbwb	Cathepsin	Protein	55.77±1.00	61.18±6.23	0.2115
		mRNA	−3.8	−2.1	0.5149
	Progerin	Protein	56.31±5.13	22.34±2.15	0.0004
		mRNA	−1.9	−1.6	0.8165
UVBnb	Cathepsin	Protein	63.41±0.26	46.63±2.05	0.0001
		mRNA	−0.9	−4.4	0.0129
	Progerin	Protein	54.42±5.70	20.93±2.96	<0.0001
		mRNA	−2.4	−0.4	0.0006

Figure 1 Alterations in progerin (A) and cathepsin K (B) mRNA relative expression (-ΔCt) after exposure to different wavelengths of UVR. Asterisks above columns indicate level of statistical significance (* p<0.05, **p<0.001). Data presented as means (horizontal black line within box) with standard deviation (boxes).

Figure 2 Alterations in progerin (A) and cathepsin K (B) protein expression after exposure to different wavelengths of UVR. Asterisks above columns indicate level of statistical significance (* p<0.05, **p<0.001, ***p<0.0001). Data presented as means (boxes) with standard deviation (whiskers). Corresponding Western blot bands are shown below each graph.

Discussion

UV radiation reaching Earth consists of several wavelengths with different biological effects.^25,26 UVA (315–400 nm), which is barely absorbed by DNA, UVB (280–315 nm), which is directly absorbed by DNA inducing photochemical reactions, and UVC (100–280 nm) which hardly reaches Earth’s surface.^26,27 UVA penetrates deeper into the skin and is considered a main factor responsible for extracellular matrix degeneration observed in photoaged skin, although recent studies have shown that UVB is also able to reach into the upper parts of the dermis, and through epidermal-dermal signaling to degrade collagen, which is one of the hallmarks of photoaging.²⁸ Cathepsin K (catK) is considered one of the most potent collagenases due to its ability to degrade type-I collagen at multiple sites.²⁹ Increased expression of catK has been found in scars³⁰ and skin tumors^31,32 and has been linked with preserving normal structure of the skin.³³ Little is known, however, about the influence of UVR on catK activity. Codriansky et al.⁸ found that UVA (dose range from 100 to 500 kJ/m²) induces expression of catK in both cultured neonatal fibroblasts and dermal fibroblasts from skin explants and that its expression is dose-dependent.⁸ Interestingly, they revealed that in old fibroblasts (taken from donors aged 60–67 years old) catK is not activated in response to UVA (300 kJ/m²) in all measured time points (2–4 days after irradiation).⁸ Induced expression of catK was also found after UVB irradiation in both neonatal fibroblasts (100 J/m² dose) and dermal fibroblasts from skin explants (200 and 500 J/m² doses) but was not so pronounced as with UVA.⁸ These findings were confirmed by Xu et al.⁷ who observed a dose-dependent induction of catK mRNA and protein after exposure to 100, 200 and 300 kJ/m² UVA doses in human dermal fibroblasts isolated from circumcised foreskins of donors aged 6–9 years old.⁷ In our study, we currently have not obtained catK mRNA induction or increased protein expression after exposure to both acute and chronic UVA/UVB irradiation; catK mRNA and protein expression was decreased as observed in old fibroblasts. Since we used irradiation doses within the range of previously performed experiments (150 kJ/m² UVA, 300 J/m² UVB) it seems that fetal dermal fibroblasts do not express catK activity in response to UVA/UVB irradiation, however more studies are needed to prove this hypothesis.

HGPS is a rare genetic disorder driven by an accumulation of an abnormal form of lamin A, known as progerin.²² For several years HGPS served as a model disease in the studies concerning aging processes suggesting that progerin expression could be linked with inflammation,³⁴ neurodegeneration,³⁵ and carcinogenesis,³⁶ however no exact mechanisms have been established yet. It also remains unsolved how progerin participates in premature skin aging which is observed in patients with HGPS as loss of subcutaneous fat, alopecia, nail dystrophy, thinning and excessive wrinkling of the skin.^16,37 In normal conditions, skin differentiation and stratification is preserved by a mechanism in which epidermal stem cells undergo asymmetric cell division producing two daughter cells, with one remaining in the basal lamina, and the second migrates to suprabasal layers and further differentiates.³⁸ It is hypothesized that, in HGPS, progerin expression causes stem cell depletion which eventually results in a reduced capacity to maintain tissue homeostasis.^39,40 To study the potential role of progerin in premature skin aging Sola-Carvajal et al.⁴¹ using an HGPS murine model discovered that accumulation of progerin in epidermal stem cells causes a shift toward symmetric cell division, in which both daughter cells are differentiating, eventually leading to depletion of epidermal stem cells and interrupted skin development.⁴¹ They have also found that the presence of progerin in the nuclear envelope enhances stem cell depletion by the disruption of Wnt/β−catenin signaling responsible for the preservation of stem cell equilibrium, which partially explains premature loss of regeneration mechanisms observed in HGPS.⁴¹ Some recent findings also indicate that UV radiation could induce progerin expression, thus resulting in premature skin aging.¹⁵ In our previous paper,⁴² we demonstrated that progerin is mainly expressed after excessive exposure to sunlight and that this is almost exclusively limited to dermal fibroblasts,⁴² therefore, to address new questions, we decided to study the effects of different doses of UV radiation on the expression of progerin. In our current study, we showed that a single high dose of UVA irradiation (150 J/m²) does not induce expression of progerin mRNA and decreases progerin protein expression. It seems to be opposing findings made by Takeuchi and Rünger;¹⁵ they described increased progerin expression both after single and repeated UVA irradiations. Takeuchi and Rünger revealed that acute exposure of primary human dermal fibroblasts to different doses of UVA (80 and 120 kJ/m²) results in an increase of progerin mRNA expression 8 and 24 hours after irradiation. Interestingly, progerin mRNA induction after exposure to repeated doses of UVA has been observed only in aged cells taken from older donors and they did not observe induction of progerin even after both acute and chronic UVB irradiations, which contradicts our results. Nevertheless, several differences in study design should be emphasized; we performed our study on a cultured commercial line of fibroblasts, irradiating them with higher acute doses of UVA, but lower chronic UVA doses – in our study, we decided to employ equal cumulative doses of UVA and UVB; we also decided to use both narrow and broadband UVB irradiation to evaluate whether the induction of progerin is wavelength-dependent. We observed a decrease of progerin mRNA after both narrow and broadband UVB after 24 hours, which suggests that UVB could also be responsible for the accumulation of progerin, which has not been previously observed. We hypothesize that the formation of a lamin A-progerin complex is not only limited to UVA, but also appears in UVB, which would explain the observed decrease in progerin protein expression after irradiations with UVA/UVB. Motegi et al.⁴³ evaluated whether UVA-induced photoaging could be accelerated in fibroblasts with existing mutations within the LMNA gene. They cultured fibroblasts derived from patients with atypical progeroid syndrome (APS) and performed single dose irradiation of 100 kJ/m² and 200 kJ/m² UVA. It was found that UVA irradiation results in increased production of abnormally shaped, HGPS-like cell nuclei in APS fibroblasts, as well as an elevated apoptotic/necrotic rate of these cells in comparison to normal fibroblasts.⁴³ It has also been shown that UVA irradiation induces progerin mRNA expression in normal fibroblasts, however, they did not observe UVA-induced progerin accumulation in APS fibroblasts indicating that apoptosis/necrosis in APS fibroblasts does not depend solely on the accumulation of progerin.⁴³ There are several limitations to our study; firstly, we did not evaluate the viability and morphology of irradiated cells nor performed an intervention to modulate the cellular response and secondly, we did not evaluate the enzymatic activity of cathepsin K, thus opening the field for further research and discussion.

Conclusion

Single high-doses of UVA, UVBwb and UVBnb resulted in the decreased expression of cathepsin K and progerin protein/mRNA in all subsequent time points. Repeated exposure to low doses of UVA results in a significant increase of progerin mRNA and a significant decrease of progerin protein after 48 hours, but repeated exposure to UVBwb and UVBnb resulted in decreased progerin mRNA and protein expression. Repeated exposure to UVA, UVBwb and UVBnb resulted in decreased cathepsin K protein and mRNA expression. These results suggest that there could be another progerin/cathepsin K regulatory pathway, which has not been described yet. Having obtained results that contradict previous research, the influence of UVR on progerin and cathepsin K needs to be further elucidated.

Acknowledgments

The study was funded by Medical University of Lodz (project no. 503/5-064-01/503-1) and The National Centre of Science (grant nos. 2017/25/N/NZ5/02064 and 2017/27/B/NZ5/02011).

Disclosure

The authors report no conflicts of interest in this work.